Synthesis and Structure-Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands

被引:7
作者
Corrado, Sandra [1 ]
Battisti, Umberto M. [1 ]
Sorbi, Claudia [1 ]
Tait, Annalisa [1 ]
Malfacini, Davide [2 ,3 ]
Camarda, Valeria [2 ,3 ]
Calo, Girolamo [2 ,3 ]
Brasili, Livio [1 ]
机构
[1] Univ Modena & Reggio Emilia, Dept Life Sci, I-41125 Modena, Italy
[2] Univ Ferrara, Dept Med Sci, Pharmacol Sect, I-44121 Ferrara, Italy
[3] Univ Ferrara, Natl Inst Neurosci, I-44121 Ferrara, Italy
关键词
agonists; NOP ligands; ORL-1; spiroxatrine; triazaspirodecanone; ORPHANIN-FQ; ORL1; AGONIST; PHARMACOLOGY; ANTAGONIST; PEPTIDE; ANALOGS; PROFILE;
D O I
10.1111/cbdd.12505
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several spiroxatrine derivatives were synthesized and evaluated as potential NOP receptor ligands. Structural modifications of the 1,4-benzodioxane moiety of spiroxatrine have been the focus of this research project. The structure-activity relationships that emerged indicate that the presence of an H-bond donor group (hydroxyl group) is more favorable for NOP activity when it is positioned with respect to the CH2 linked to the 1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one portion. Moreover, cis diastereoisomers of the hydroxyl derivatives4 and 22 show a moderately higher degree of stereoselectivity than trans isomers. In particular, the spiropiperidine derivative cis-4 has submicromolar agonistic activity, and it will be the reference compound for the design and synthesis of new NOP agonists.
引用
收藏
页码:447 / 458
页数:12
相关论文
共 31 条
[1]   A new efficient synthesis of 3-(hydroxymethyl)-4H-chromen-4-ones [J].
Bolós, J ;
Loscertales, T ;
Nieto, J ;
Sacristán, A ;
Ortiz, JA .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2000, 37 (05) :1203-1208
[2]   (4+2) CYCLOADDITION OF KETENES AND BETA-METHOXY ALPHA,BETA-UNSATURATED KETONES - 2-PYRANONES [J].
BRADY, WT ;
AGHO, MO .
JOURNAL OF ORGANIC CHEMISTRY, 1983, 48 (26) :5337-5341
[3]   Synthesis and structure-activity relationships of N-substituted spiropiperidines as nociceptin receptor ligands [J].
Caldwell, John P. ;
Matasi, Julius J. ;
Zhang, Hongtao ;
Fawzi, Ahmad ;
Tulshian, Deen B. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (08) :2281-2284
[4]   Pharmacology of nociceptin and its receptor: a novel therapeutic target [J].
Calo, G ;
Guerrini, R ;
Rizzi, A ;
Salvadori, S ;
Regoli, D .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (07) :1261-1283
[5]  
Camarda Valeria, 2013, Methods Mol Biol, V937, P293
[6]   Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 [J].
Camarda, Valeria ;
Fischetti, Carmela ;
Anzellotti, Nicholas ;
Molinari, Paola ;
Ambrosio, Caterina ;
Kostenis, Evi ;
Regoli, Domenico ;
Trapella, Claudio ;
Guerrini, Remo ;
Severo, Salvadori ;
Calo, Girolamo .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 (06) :599-607
[7]   Nociceptin/orphanin FQ peptide receptors: Pharmacology and clinical implications [J].
Chiou, L. -C. ;
Liao, Y. -Y. ;
Fan, P. -C. ;
Kuo, P. -H. ;
Wang, C. -H. ;
Riemer, C. ;
Prinssen, E. P. .
CURRENT DRUG TARGETS, 2007, 8 (01) :117-135
[8]   Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 [J].
Fischetti, Carmela ;
Camarda, Valeria ;
Rizzi, Anna ;
Pela, Michela ;
Trapella, Claudio ;
Guerrini, Remo ;
McDonald, John ;
Lambert, David G. ;
Salvadori, Severo ;
Regoli, Domenico ;
Calo, Girolamo .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 614 (1-3) :50-57
[9]   A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat [J].
Jenck, F ;
Wichmann, J ;
Dautzenberg, FM ;
Moreau, JL ;
Ouagazzal, AM ;
Martin, JR ;
Lundstrom, K ;
Cesura, AM ;
Poli, SM ;
Roever, S ;
Kolczewski, S ;
Adam, G ;
Kilpatrick, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (09) :4938-4943
[10]   The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential [J].
Lambert, David G. .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (08) :694-U11